The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients
Open accessAbstract
Background: Cerebral venous and sinus thrombosis (CVST) is a rather rare disease which accounts for <1% of all strokes. Diagnosis is still frequently overlooked or delayed as a result of the wide spectrum of clinical symptoms and the often subacute or lingering onset. Current therapeutic measures which are used in clinical practice include the use of anticoagulants such as dose‐adjusted intravenous heparin or body weight‐adjusted subcutaneous low‐molecular‐weight heparin (LMWH), the use of thrombolysis and symptomatic therapy including control of seizures and elevated intracranial pressure. Methods: We searched MEDLINE (National Library of Medicine), the Cochrane Central Register of Controlled Trials (CENTRAL) and the Cochrane Library to review the strength of evidence to support these interventions and the preparation of recommendations on the therapy of CVST based on the best available evidence. Review articles and book chapters were also included. Recommendations were reached by consensus. Where there was a lack of evidence but consensus was clear we stated our opinion as good practice points. Results and conclusions: Patients with CVST without contraindications for anticoagulation (AC) should be treated either with body weight‐adjusted subcutaneous LMWH or with dose‐adjusted intravenous heparin (level B recommendation). Concomitant intracranial haemorrhage (ICH) related to CVST is not a contraindication for heparin therapy. The optimal duration of oral anticoagulant therapy after the acute phase is unclear. Oral AC may be given for 3 months if CVST was secondary to a transient risk factor, for 6–12 months in patients with idiopathic CVST and in those with “mild” thrombophilia, such as heterozygous factor V Leiden or prothrombin G20210A mutation and high plasma levels of factor VIII. Indefinite AC should be considered in patients with recurrent episodes of CVST and in those with one episode of CVST and ‘severe’ thrombophilia, such as antithrombin, protein C or protein S deficiency, homozygous factor V Leiden or prothrombin G20210A mutation, antiphospholipid antibodies and combined abnormalities (good practice point). There is insufficient evidence to support the use of either systemic or local thrombolysis in patients with CVST. If patients deteriorate despite adequate AC and other causes of deterioration have been ruled out, thrombolysis may be a therapeutic option in selected cases, possibly in those without large ICH and threatening herniation (good practice point). There are no controlled data about the risks and benefits of certain therapeutic measures to reduce an elevated intracranial pressure (with brain displacement) in patients with severe CVST. However, in severe cases with impending herniation craniectomy can be used as a life‐saving intervention (good practice point).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferro, J. M., Canhão, P., Stam, J., Bousser, M.-G., & Barinagarrementeria, F. (2004) · Stroke · doi:10.1161/01.str.0000117571.76197.26 · Cited by 2,315
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Cerebral Sinovenous Thrombosis in Children
deVeber, G., Andrew, M., Adams, C., Bjornson, B., Booth, F., Buckley, D. J., Camfield, C. S., David, M., Humphreys, P., Langevin, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450604 · Cited by 1,139
Heparin treatment in sinus venous thrombosis
Einhäupl, K. M., Villringer, A., Mehraein, S., Garner, C., Pellkofer, M., Haberl, R. L., Pfister, H.-W., Schmiedek, P., & Meister, W. (1991) · The Lancet · doi:10.1016/0140-6736(91)90607-q · Cited by 992
Self-citationde Bruijn, S. F. T. M., & Stam, J. (1999) · Stroke · doi:10.1161/01.str.30.3.484 · Cited by 817
Self-citationAmeri, A., & Bousser, M.-G. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30235-4 · Cited by 795
Self-citationCerebral venous thrombosis--a review of 38 cases.
Bousser, M. G., Chiras, J., Bories, J., & Castaigne, P. (1985) · Stroke · doi:10.1161/01.str.16.2.199 · Cited by 778
Self-citationCauses and Predictors of Death in Cerebral Venous Thrombosis
Canhão, P., Ferro, J. M., Lindgren, A. G., Bousser, M.-G., Stam, J., & Barinagarrementeria, F. (2005) · Stroke · doi:10.1161/01.str.0000173152.84438.1c · Cited by 482
Self-citationvan Dongen, C. J., van den Belt, A. G., Prins, M. H., & Lensing, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001100.pub2 · Cited by 433
Cited by
Sacco, R. L., Kasner, S. E., Broderick, J. P., Caplan, L. R., Connors, J. J. (., Culebras, A., Elkind, M. S. V., George, M. G., Hamdan, A. D., Higashida, R. T., et al. (2013) · Stroke · doi:10.1161/str.0b013e318296aeca · Cited by 3,569
Ferro, J. M., Bousser, M. ‐., Canhão, P., Coutinho, J. M., Crassard, I., Dentali, F., di Minno, M., Maino, A., Martinelli, I., Masuhr, F., et al. (2017) · European Journal of Neurology · doi:10.1111/ene.13381 · Cited by 749
Self-citationFrontera, J. A., Lewin III, J. J., Rabinstein, A. A., Aisiku, I. P., Alexandrov, A. W., Cook, A. M., del Zoppo, G. J., Kumar, M. A., Peerschke, E. I. B., Stiefel, M. F., et al. (2016) · Neurocritical Care · doi:10.1007/s12028-015-0222-x · Cited by 706
Ferro, J. M., Coutinho, J. M., Dentali, F., Kobayashi, A., Alasheev, A., Canhão, P., Karpov, D., Nagel, S., Posthuma, L., Roriz, J. M., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2764 · Cited by 311
Self-citationSaposnik, G., Bushnell, C., Coutinho, J. M., Field, T. S., Furie, K. L., Galadanci, N., Kam, W., Kirkham, F. C., McNair, N. D., Singhal, A. B., et al. (2024) · Stroke · doi:10.1161/str.0000000000000456 · Cited by 306
Metadata
- Authors
- Einhäupl, K., Stam, J., Bousser, M. ‐., De Bruijn, S. F. T. M., Ferro, J. M., Martinelli, I., & Masuhr, F.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2010-09-13
- Volume
- 17
- Issue
- 10
- Pages
- 1229-1235
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2128625682
- Cited by
- 528
- References
- 28
- FWCI
- 20.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. https://app.cochat.ai/papers/10.1111/j.1468-1331.2010.03011.x
- The paper
- Einhäupl, K., Stam, J., Bousser, M. ‐., De Bruijn, S. F. T. M., Ferro, J. M., Martinelli, I., & Masuhr, F. (2010). EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2010.03011.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.